Company Overview and News

15
Comparing Annaly Capital's BV, Dividend, And Valuation To 20 mREIT Peers (Post Q2 2018 Earnings) - Part 1

11h seekingalpha
Part 1 of this article compares NLY’s recent leverage, hedging coverage ratio, quarterly BV, economic loss, and current valuation to twenty mREIT peers.
ANH NYMTO ORC CHMI NYMTP CIM AI CMO TWO AGNC AIW GPMT MO WMC NRZ AIC CYS 511505 CAPITALT MITT MFO DX NLY ARR BXMT MFA IVR NYMT

1
66 Hot Dividend Dogs Boosted By Wall Street Sizzle In August.

2018-08-14 seekingalpha
WallStars show positive broker target price-upsides. 66 displayed 10%+ forward yield, at $2+ prices, and $10M+ market caps as of 8/9/18. Yields above 11.88% narrowed this WallStar list to 30.
SNR.WI NGL SNR AIC MCQ MMLP MCV BBDC PER HCLP SNR MCX AI GMLP MDLY CVRR AIW SNMP MCC

30
Annaly Capital And Arlington Asset Investment: MBS Pricing For First Half Of Q3 2018 (Includes Current BV Projections)

2018-08-13 seekingalpha
Following continued requests, this article analyzes fixed-rate agency MBS price movements during the third quarter of 2018 (through 8/10/2018).
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC IVR NYMT FMCCS FMCCT

16
Analyzing AGNC Investment's Results For Q2 2018 (Including August-October 2018 Dividend Projection)

2018-08-01 seekingalpha
On 7/25/2018, AGNC reported results for the second quarter of 2018. AGNC reported comprehensive income of $148 million and a non-tangible BV as of 6/30/2018 of $19.68 per common share.
NYMTO ORC CHMI NYMTP AI CMO TWO AGNC AIW MO NRZ AIC CYS ARR BXMT 511505 NYMT CAPITALT

0
Arlington Asset Investment Corporation 2018 Q2 - Results - Earnings Call Slides

2018-07-25 seekingalpha
The following slide deck was published by Arlington Asset Investment Corporation in conjunction with their 2018 Q2 earnings call.
AI AIC AIW

0
Arlington Asset Investment Corporation (AI) CEO Rock Tonkel on Q2 2018 Results - Earnings Call Transcript

2018-07-25 seekingalpha
Arlington Asset Investment Corporation (NYSE:AI) Q2 2018 Earnings Conference Call July 25, 2018 9:00 AM ET
AI AIC AIW

13
AGNC Investment's Q2 2018 And 7/13/2018 BV Projection (Includes NLY BV Projection)

2018-07-18 seekingalpha
I am projecting AGNC will report a minor decrease in quarterly BV for the second quarter of 2018. Most agency peers will also experience a similar type of BV decrease.
NYMTO ORC CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS MTGE MITT MFO DX NLY ARR MFA HTS IVR NYMT

29
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 3 (Modest MBS Price Decreases)

2018-07-16 seekingalpha
I am projecting AGNC will report a combined modest-notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the second quarter of 2018.
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC HTS IVR NYMT FMCCS FMCCT

13
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 2 (Hedges To The Rescue Once Again)

2018-07-09 seekingalpha
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the second quarter of 2018.
NYMTO MTGE ORC CHMI NYMTP AI TWO AGNC AIW NRZ AIC NLY CYS ARR NYMT

56
High-Yield Investment Strategy Fails

2018-07-03 seekingalpha
The performance of 59 securities, which were selected by SA contributors for their high-yield portfolios in 2014, are identified and analyzed for the period May 2014 to July 2018.
AIY AINV ARI PCI NYMTO HTF KAP OSLE NYMTP KCAP FGB AI CMO TWO SDRL HTFA AGNC AIW SLRA RSO WMC AIC AIB TCRD PSEC NMFC CYS AIF TSLF MCX SCQ XAN PBB SCA MCQ HRZN CHW OXLCO MCV OXLCN STWD.WI MITT SCM HTGZ SLRC BIT MCC TCRX ARCC GBDC CLMT MFO DX NLY TCPC TCRZ HTGX OXLC HTGY ARU OCSL EFC MFA NYMT HTGC STWD

52
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 1 (Including Current Recommendation)

2018-07-02 seekingalpha
This series projects AGNC’s income statement for the second quarter of 2018. These projections help readers understand how most of the fixed-rate agency mREIT sector performed.
NYMTO ORC CHMI NYMTP AI TWO AGNC AIW NRZ AIC NLY CYS ARR HTS NYMT

38
Sector Of Headwinds

2018-06-26 seekingalpha
iShares Mortgage Real Estate Capped ETF offer investors a high yield, but the risks are great.
AIC NLY ARR REM AI AGNC AIW

77
Ain't Nothing Like The REIT Thing

2018-06-26 seekingalpha
REIT headwinds persist, including rising interest rates and bond yields, as well as the pro-growth, risk-on environment.
REG GEO BPY ARI OPRF KRG AI LADR EQR GGP UMH AIW AVB CORR NRZ AIC O NLY EPR CBL

73
Annaly Capital's BV, Dividend, And Valuation Compared To 20 MREIT Peers (Includes Q3 2018 Dividend Projection) - Part 2

2018-06-26 seekingalpha
This article compares NLY’s recent dividend per share rates, yield percentages, and several dividend sustainability metrics to twenty mREIT peers.
ANH NYMTO IRC ORC CHMI NYMTP AI CMO TWO AGNC AIW GPMT WMC NRZ AIC CYS 511505 CAPITALT MITT MFO DX NLY ARR BXMT MFA IVR NYMT

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...